Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
Research ArticleSpecial Contributions

Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites

Wolfgang Peter Fendler, Johannes Czernin, Ken Herrmann and Thomas Beyer
Journal of Nuclear Medicine December 2016, 57 (12) 2016-2021; DOI: https://doi.org/10.2967/jnumed.116.174169
Wolfgang Peter Fendler
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Beyer
2Centre of Medical Physics and Biomedical Engineering, QIMP, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Survey of 39 PET/MRI sites by location (A), vendor (B), and first year of operation (C). PET/MRI location was categorized into (from left to right) North America, Western Europe, Eastern Europe, Asia, and Australia.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Present clinical and research applications. Most prevalent clinical and research applications have been categorized into cardiology (Cardio), neurology (Neuro), other, or oncology (Onco). Oncology was further subdivided by tumor type. GI = gastrointestinal; Gyn = gynecologic; H&N = head & neck; Hem = hematologic.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Present (A) and future (B) key applications. Participants listed up to 3 key applications for present and future PET/MRI use. Cardiovasc = cardiovascular; Gyn = gynecologic; H&N = head and neck; Neuro = neurologic; Onco = oncologic; Ped = pediatric; RT = radiation therapy.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    PET/MRI Financial Resources As Well As Clinical Responsibility Separated by Provider

    CategoryAllPrivatePublicJointNucRadOther
    n3910291113105
    Funded by
     Hospital10 (26%)3 (30%)7 (24%)3 (27%)3 (23%)4 (40%)0
     Government7 (18%)07 (24%)3 (27%)01 (10%)3 (60%)
     Private11 (28%)5 (50%)6 (21%)3 (27%)5 (38%)3 (30%)0
     Res grant11 (28%)2 (20%)9 (31%)2 (18%)5 (38%)2 (20%)2 (40%)
    Reported by
     Joint30 (77%)7 (70%)23 (79%)10 (91%)12 (92%)5 (50%)3 (60%)
     Nuc only1 (3%)1 (10%)001 (8%)00
     Res only3 (8%)03 (10%)001 (10%)2 (40%)
     Rad only5 (13%)2 (20%)3 (10%)1 (9%)04 (40%)0
    MRI-only scans25 (64%)8 (80%)17 (59%)7 (64%)7 (54%)7 (70%)4 (80%)
    • Joint = Joint Nuclear Medicine/Radiology Department; Nuc = Nuclear Medicine Department; Rad = Radiology Department; Res = research.

    • Absolute numbers, with percentages in parentheses, are given.

    • View popup
    TABLE 2

    Scan Time and Tracer Separated by Field of Application

    ParameterCardiologyNeurologyOncology
    Typical duration of scan (min)60 (30–120)45 (10–120)60 (30–100)
    Top 3 tracer used
     118F-FDG18F-FDG18F-FDG
     213N-NH3OtherOther
     3Other18F-FETPSMA ligands
    • PSMA = prostate-specific membrane antigen.

    • Median, with range in parentheses, is given for typical duration of PET/MRI scans. Data are from 39 responding sites.

    • View popup
    TABLE 3

    Timeline for Clinical Adoption of PET/MRI

    ParameterAllPrivatePublic
    n391029
    In how many years  will PET/MRI excel  in clinical routine?
     14 (10%)04 (14%)
     313 (33%)5 (50%)8 (28%)
     515 (38%)2 (20%)13 (45%)
     106 (15%)3 (30%)3 (10%)
     >101 (3%)01 (3%)

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (12)
Journal of Nuclear Medicine
Vol. 57, Issue 12
December 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
Wolfgang Peter Fendler, Johannes Czernin, Ken Herrmann, Thomas Beyer
Journal of Nuclear Medicine Dec 2016, 57 (12) 2016-2021; DOI: 10.2967/jnumed.116.174169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
Wolfgang Peter Fendler, Johannes Czernin, Ken Herrmann, Thomas Beyer
Journal of Nuclear Medicine Dec 2016, 57 (12) 2016-2021; DOI: 10.2967/jnumed.116.174169
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Synthesis of Patient-Specific Transmission Data for PET Attenuation Correction for PET/MRI Neuroimaging Using a Convolutional Neural Network
  • Google Scholar

More in this TOC Section

  • The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents
  • American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET
Show more Special Contributions

Similar Articles

Keywords

  • PET/MRI
  • survey
  • imaging protocols
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire